BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 17928177)

  • 1. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.
    Piao ZZ; Lee MK; Lee BJ
    Int J Pharm; 2008 Feb; 350(1-2):205-11. PubMed ID: 17928177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F.
    Hu Z; Shimokawa T; Ohno T; Kimura G; Mawatari SS; Kamitsuna M; Yoshikawa Y; Masuda S; Takada K
    J Drug Target; 1999; 7(3):223-32. PubMed ID: 10680978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F; Moreno P; Basit AW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
    Kadam VD; Gattani SG
    Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
    Kaur K; Kim K
    Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation of paeonol-beta-cyclodextrin inclusion complex loaded colon specific delivery tablets].
    Wang T; Cui Q; Cao Q; Cui J
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):2956-9. PubMed ID: 22308682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet.
    Park HJ; Jung HJ; Ho MJ; Lee DR; Cho HR; Choi YS; Jun J; Son M; Kang MJ
    Eur J Pharm Sci; 2017 May; 102():172-179. PubMed ID: 28279763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
    Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
    Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions.
    Cao QR; Choi HG; Kim DC; Lee BJ
    Int J Pharm; 2004 Apr; 274(1-2):107-17. PubMed ID: 15072787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H; McGinity JW
    Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naproxen-Eudragit microspheres: screening of process and formulation variables for the preparation of extended release tablets.
    Zaghloul AA; Faltinek J; Vaithiyalingam SR; Reddy IK; Khan MA
    Pharmazie; 2001 Apr; 56(4):321-4. PubMed ID: 11338673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma.
    Kadam VD; Gattani SG
    Drug Deliv; 2010 Jul; 17(5):343-51. PubMed ID: 20429842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gastro-resistant ovalbumin bi-layered mini-tablet-in-tablet system for the delivery of Lactobacillus acidophilus probiotic to simulated human intestinal and colon conditions.
    Govender M; Choonara YE; van Vuuren S; Kumar P; du Toit LC; Pillay V
    J Pharm Pharmacol; 2015 Jul; 67(7):939-50. PubMed ID: 25645491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).
    Leopold CS; Eikeler D
    J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.